TLR7 and melanoma: In accordance with our in vitro findings that AdjFluVx did not stimulate TLR7, intratumoral administration of AdjFluVx in WT and TLR7-/- mice bearing B16 melanoma tumors did not experience any change in tumor progression (Figures 2D, E).